What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Meurer
L N
LN
Medical College of Wisconsin, Milwaukee, USA. lmeurer@mcw.edu
Slawson
J G
JG
D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D017135:Desogestrel / Q000009:adverse effects; D006801:Humans; D016912:Levonorgestrel / Q000009:adverse effects*; D009652:Norpregnenes / Q000009:adverse effects; D045167:Progesterone Congeners / Q000009:adverse effects*; D012307:Risk Factors; D013923:Thromboembolism / Q000139:chemically induced*; D020246:Venous Thrombosis / Q000139:chemically induced*
D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003280:Contraceptives, Oral, Synthetic; D009652:Norpregnenes; D045167:Progesterone Congeners; C033273:Gestodene; D016912:Levonorgestrel; D017135:Desogestrel